DAVID KROIN
CIK 1397513 · last filed 2018-09-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$102.10M
Companies
4
Total Filings
42
Lifetime Open-Market Net
-$37.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | 4,781,708 | — | — | $0 | 1 | 2018-09-14 | |
| INFU | 10%+ Owner | 1,955,000 | $10.05 | $19.65M | -$30.46M | 1 | 2011-02-10 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | Director | 2,821,762 | — | — | -$7.22M | 39 | 2010-03-03 |
| MEMY | 10%+ Owner | 4,059,852 | $20.31 | $82.46M | -$74.7K | 1 | 2008-12-11 |
Recent Filings · Page 2 of 5
42 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-09-16 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −53,800 | -$283.2K | EDGAR |
| 2009-09-14 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −17,200 | -$89.2K | EDGAR |
| 2009-09-10 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −9,006 | -$46.2K | EDGAR |
| 2009-09-01 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −7,800 | -$39.3K | EDGAR |
| 2009-08-28 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −11,800 | -$60.7K | EDGAR |
| 2009-08-26 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −29,200 | -$152.3K | EDGAR |
| 2009-08-24 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −16,200 | -$81.5K | EDGAR |
| 2009-08-18 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −5,419 | -$27.2K | EDGAR |
| 2009-08-14 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −1,099 | -$5.5K | EDGAR |
| 2009-08-12 | ALBIREO PHARMA, INC. (BIOD) Delisted | Sell (S) | −4,400 | -$22.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.